
Mark L. Berch
Examiner (ID: 99)
| Most Active Art Unit | 1202 |
| Art Unit(s) | 1202, 1624, 1622, 1802, 2899, 1614, 1611 |
| Total Applications | 3573 |
| Issued Applications | 2301 |
| Pending Applications | 170 |
| Abandoned Applications | 1103 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7469630
[patent_doc_number] => 20040102459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Purine derivatives as purinergic receptor antagonists'
[patent_app_type] => new
[patent_app_number] => 10/250941
[patent_app_country] => US
[patent_app_date] => 2003-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42638
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20040102459.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250941
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250941 | Purine derivatives as purinergic receptor antagonists | Jan 9, 2002 | Issued |
Array
(
[id] => 1265106
[patent_doc_number] => 06660745
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-09
[patent_title] => 'Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof'
[patent_app_type] => B1
[patent_app_number] => 09/926477
[patent_app_country] => US
[patent_app_date] => 2002-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5508
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/660/06660745.pdf
[firstpage_image] =>[orig_patent_app_number] => 09926477
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/926477 | Purine derivative dihydrate, drugs containing the same as the active ingredient and intermediate in the production thereof | Jan 8, 2002 | Issued |
Array
(
[id] => 5988030
[patent_doc_number] => 20020099206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'Cephalosporin crystals and process for their preparation'
[patent_app_type] => new
[patent_app_number] => 10/040365
[patent_app_country] => US
[patent_app_date] => 2002-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4094
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20020099206.pdf
[firstpage_image] =>[orig_patent_app_number] => 10040365
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/040365 | Cephalosporin crystals and process for their preparation | Jan 8, 2002 | Abandoned |
Array
(
[id] => 6660397
[patent_doc_number] => 20030135041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Synthesis of ceftiofur intermediate'
[patent_app_type] => new
[patent_app_number] => 10/035178
[patent_app_country] => US
[patent_app_date] => 2002-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1811
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20030135041.pdf
[firstpage_image] =>[orig_patent_app_number] => 10035178
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/035178 | Synthesis of ceftiofur intermediate | Jan 3, 2002 | Abandoned |
Array
(
[id] => 1314700
[patent_doc_number] => 06610845
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-26
[patent_title] => 'Thioester derivatives of thiazolyl acetic acid and their use in the preparation of cephalosporin compounds'
[patent_app_type] => B1
[patent_app_number] => 10/035177
[patent_app_country] => US
[patent_app_date] => 2002-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3158
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/610/06610845.pdf
[firstpage_image] =>[orig_patent_app_number] => 10035177
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/035177 | Thioester derivatives of thiazolyl acetic acid and their use in the preparation of cephalosporin compounds | Jan 3, 2002 | Issued |
Array
(
[id] => 6178772
[patent_doc_number] => 20020156278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => 'Process for the preparation of pure triethylenediamine (TEDA)'
[patent_app_type] => new
[patent_app_number] => 10/033915
[patent_app_country] => US
[patent_app_date] => 2002-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4732
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20020156278.pdf
[firstpage_image] =>[orig_patent_app_number] => 10033915
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/033915 | Process for the preparation of pure triethylenediamine (TEDA) | Jan 2, 2002 | Issued |
Array
(
[id] => 6839310
[patent_doc_number] => 20030036650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-20
[patent_title] => 'Intermediates for and synthesis of 3-methylene cephams'
[patent_app_type] => new
[patent_app_number] => 09/958857
[patent_app_country] => US
[patent_app_date] => 2001-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6340
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0036/20030036650.pdf
[firstpage_image] =>[orig_patent_app_number] => 09958857
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/958857 | Intermediates for and synthesis of 3-methylene cephams | Dec 30, 2001 | Issued |
Array
(
[id] => 6308212
[patent_doc_number] => 20020095034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-18
[patent_title] => 'Imipenem production process'
[patent_app_type] => new
[patent_app_number] => 10/032034
[patent_app_country] => US
[patent_app_date] => 2001-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2500
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20020095034.pdf
[firstpage_image] =>[orig_patent_app_number] => 10032034
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/032034 | Imipenem production process | Dec 30, 2001 | Abandoned |
Array
(
[id] => 6439618
[patent_doc_number] => 20020128254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Crystalline 1-methylcarbapenem derivatives'
[patent_app_type] => new
[patent_app_number] => 10/034548
[patent_app_country] => US
[patent_app_date] => 2001-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7811
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20020128254.pdf
[firstpage_image] =>[orig_patent_app_number] => 10034548
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/034548 | Crystalline 1-methylcarbapenem derivatives | Dec 27, 2001 | Abandoned |
Array
(
[id] => 7605334
[patent_doc_number] => 07115595
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-03
[patent_title] => 'Carbapenem compounds'
[patent_app_type] => utility
[patent_app_number] => 10/465918
[patent_app_country] => US
[patent_app_date] => 2001-12-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15737
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/115/07115595.pdf
[firstpage_image] =>[orig_patent_app_number] => 10465918
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/465918 | Carbapenem compounds | Dec 24, 2001 | Issued |
Array
(
[id] => 6439607
[patent_doc_number] => 20020128253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use'
[patent_app_type] => new
[patent_app_number] => 10/021044
[patent_app_country] => US
[patent_app_date] => 2001-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5328
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20020128253.pdf
[firstpage_image] =>[orig_patent_app_number] => 10021044
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/021044 | Diphenylazetidinone derivatives, process for their preparation, medicaments comprising these compounds and their use | Dec 18, 2001 | Issued |
Array
(
[id] => 1308531
[patent_doc_number] => 06617451
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-09
[patent_title] => 'Enantioselective acylation of cis racemic azetidinones'
[patent_app_type] => B1
[patent_app_number] => 10/018187
[patent_app_country] => US
[patent_app_date] => 2001-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5933
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/617/06617451.pdf
[firstpage_image] =>[orig_patent_app_number] => 10018187
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/018187 | Enantioselective acylation of cis racemic azetidinones | Dec 12, 2001 | Issued |
Array
(
[id] => 1383239
[patent_doc_number] => 06555680
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-29
[patent_title] => 'Method for the preparation of ceftiofur sodium'
[patent_app_type] => B1
[patent_app_number] => 10/006354
[patent_app_country] => US
[patent_app_date] => 2001-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3517
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/555/06555680.pdf
[firstpage_image] =>[orig_patent_app_number] => 10006354
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/006354 | Method for the preparation of ceftiofur sodium | Dec 9, 2001 | Issued |
Array
(
[id] => 6330968
[patent_doc_number] => 20020198375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => 'Coupling process and intermediates useful for preparing cephalosporins'
[patent_app_type] => new
[patent_app_number] => 10/006279
[patent_app_country] => US
[patent_app_date] => 2001-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10192
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20020198375.pdf
[firstpage_image] =>[orig_patent_app_number] => 10006279
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/006279 | Coupling process and intermediates useful for preparing cephalosporins | Dec 3, 2001 | Abandoned |
Array
(
[id] => 5988028
[patent_doc_number] => 20020099205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'Process and ester derivatives useful for preparation of cephalosporins'
[patent_app_type] => new
[patent_app_number] => 10/006579
[patent_app_country] => US
[patent_app_date] => 2001-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11874
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20020099205.pdf
[firstpage_image] =>[orig_patent_app_number] => 10006579
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/006579 | Process and ester derivatives useful for preparation of cephalosporins | Dec 3, 2001 | Abandoned |
Array
(
[id] => 1142320
[patent_doc_number] => 06777428
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-17
[patent_title] => '5-HT1f agonist'
[patent_app_type] => B1
[patent_app_number] => 09/890741
[patent_app_country] => US
[patent_app_date] => 2001-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24535
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 401
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/777/06777428.pdf
[firstpage_image] =>[orig_patent_app_number] => 09890741
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/890741 | 5-HT1f agonist | Dec 3, 2001 | Issued |
Array
(
[id] => 6362954
[patent_doc_number] => 20020058811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'Naphthalene derivatives'
[patent_app_type] => new
[patent_app_number] => 10/004990
[patent_app_country] => US
[patent_app_date] => 2001-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32091
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20020058811.pdf
[firstpage_image] =>[orig_patent_app_number] => 10004990
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/004990 | Naphthalene derivatives | Dec 2, 2001 | Abandoned |
Array
(
[id] => 6814158
[patent_doc_number] => 20030073708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Compounds specific to adenosine A3 receptor and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/006405
[patent_app_country] => US
[patent_app_date] => 2001-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42130
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073708.pdf
[firstpage_image] =>[orig_patent_app_number] => 10006405
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/006405 | Compounds specific to adenosine A3 receptor and uses thereof | Nov 29, 2001 | Issued |
Array
(
[id] => 6552848
[patent_doc_number] => 20020111333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-15
[patent_title] => 'A1 adenosine receptor antagonists'
[patent_app_type] => new
[patent_app_number] => 09/997740
[patent_app_country] => US
[patent_app_date] => 2001-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9628
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20020111333.pdf
[firstpage_image] =>[orig_patent_app_number] => 09997740
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/997740 | A1 adenosine receptor antagonists | Nov 29, 2001 | Issued |
Array
(
[id] => 1021806
[patent_doc_number] => 06887880
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-03
[patent_title] => 'Adenine based inhibitors of adenylyl cyclase, pharmaceutical compositions, and method of use thereof'
[patent_app_type] => utility
[patent_app_number] => 09/989348
[patent_app_country] => US
[patent_app_date] => 2001-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20555
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/887/06887880.pdf
[firstpage_image] =>[orig_patent_app_number] => 09989348
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/989348 | Adenine based inhibitors of adenylyl cyclase, pharmaceutical compositions, and method of use thereof | Nov 19, 2001 | Issued |